06/22/2021
7:59 AM | Intec Pharma (Subject)
| Form 425
| |
06/22/2021
7:57 AM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2021
6:00 AM | Intec Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/12/2021
4:29 PM | Intec Parent Inc. (Filer)
Intec Pharma (Filer)
| Form S-4/A
| |
04/30/2021
3:30 PM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2021
3:30 PM | Intec Pharma (Subject)
| Form 425
| |
04/20/2021
4:31 PM | Intec Parent Inc. (Filer)
Intec Pharma (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
03/17/2021
3:28 PM | Intec Pharma (Filer)
| Form 10-K/A
| |
03/16/2021
4:27 PM | Intec Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/15/2021
7:40 AM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
03/15/2021
7:38 AM | Intec Pharma (Subject)
| Form 425
| |
02/08/2021
6:00 AM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2021
5:09 AM | Intec Pharma (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
| Form SC 13G/A
| |
01/04/2021
12:40 PM | Intec Pharma (Subject)
SABBY MANAGEMENT, LLC (Filed by)
| Form SC 13G/A
| |
12/09/2020
6:07 AM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2020
7:00 AM | Intec Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2020
6:11 AM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2020
6:42 AM | Intec Pharma (Subject)
MEITAV DASH INVESTMENTS LTD (Filed by)
| Form SC 13G/A
| |
10/29/2020
7:21 AM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2020
6:08 AM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2020
4:02 PM | Intec Pharma (Issuer)
Sassi Nir (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2020
4:01 PM | Intec Pharma (Issuer)
Linscott Walt Addison (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2020
4:00 PM | Intec Pharma (Issuer)
Navon Nadav (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2020
3:30 PM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/17/2020
3:31 PM | Intec Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/05/2020
6:08 AM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2020
3:39 PM | Intec Pharma (Issuer)
Pomerantz Roger (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2020
3:38 PM | Intec Pharma (Issuer)
Meckler Jeffrey A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2020
3:34 PM | Intec Pharma (Issuer)
MADDALUNA ANTHONY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2020
3:33 PM | Intec Pharma (Issuer)
Karah Hila (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2020
3:33 PM | Hayes William B (Reporting)
Intec Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2020
3:30 PM | Intec Pharma (Issuer)
KOZARICH JOHN W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2020
3:30 PM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2020
11:15 PM | Intec Pharma (Filer)
| Form EFFECT
| |
06/08/2020
4:21 PM | Intec Pharma (Filer)
| Form DEF 14A
| |
06/08/2020
4:00 PM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2020
3:40 PM | ARMISTICE CAPITAL, LLC (Filed by)
Intec Pharma (Subject)
| Form SC 13G
| |
05/13/2020
10:52 AM | CVI Investments, Inc. (Filed by)
Intec Pharma (Subject)
| Form SC 13G
| |
05/11/2020
3:25 PM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2020
9:47 AM | Intec Pharma (Filer)
| Form 424B5
| |
05/06/2020
9:44 AM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2020
6:45 AM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/25/2020
7:32 AM | Dexcel Pharma Technologies Ltd. (Filed by)
Intec Pharma (Subject)
| Form SC 13G/A
| |
02/19/2020
8:46 PM | Intec Pharma (Issuer)
Sassi Nir (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2020
8:46 PM | Intec Pharma (Issuer)
Navon Nadav (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2020
8:45 PM | Intec Pharma (Issuer)
Linscott Walt Addison (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2020
8:45 PM | GENDREAU R MICHAEL (Reporting)
Intec Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2020
9:23 AM | Avoro Capital Advisors LLC (Filed by)
Intec Pharma (Subject)
| Form SC 13G/A
| |
02/12/2020
9:05 AM | Intec Pharma (Subject)
MEITAV DASH INVESTMENTS LTD (Filed by)
| Form SC 13G/A
| |
02/10/2020
7:50 PM | Intec Pharma (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
| Form SC 13G
| |
02/07/2020
3:49 PM | ARMISTICE CAPITAL, LLC (Filed by)
Intec Pharma (Subject)
| Form SC 13G
| |
02/05/2020
2:10 PM | Intec Pharma (Subject)
SABBY MANAGEMENT, LLC (Filed by)
| Form SC 13G
| |
02/04/2020
5:41 PM | Dexcel Pharma Technologies Ltd. (Reporting)
Intec Pharma (Issuer)
Oren Dan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2020
4:28 PM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/03/2020
4:27 PM | Intec Pharma (Filer)
| Form 424B5
| |
01/30/2020
3:40 PM | Intec Pharma (Filer)
| Form 424B5
| |
12/11/2019
6:48 AM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2019
6:40 AM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2019
6:39 AM | Intec Pharma (Filer)
| Form 424B5
| |
12/02/2019
4:21 PM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2019
4:00 PM | Intec Pharma (Issuer)
Silberman Issac (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2019
3:18 PM | Intec Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2019
3:15 PM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2019
3:15 PM | Intec Pharma (Filer)
| Form DEF 14A
| |
10/07/2019
3:52 PM | Intec Pharma (Filer)
| Form PRE 14A
| |
09/27/2019
3:16 PM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2019
8:32 PM | Intec Pharma (Issuer)
Sassi Nir (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2019
8:28 PM | Intec Pharma (Issuer)
Linscott Walt Addison (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2019
7:08 AM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2019
7:01 AM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2019
3:17 PM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2019
3:16 PM | Intec Pharma (Issuer)
Meckler Jeffrey A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2019
3:16 PM | Intec Pharma (Issuer)
MADDALUNA ANTHONY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2019
3:20 PM | Intec Pharma (Issuer)
KOZARICH JOHN W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2019
3:18 PM | Intec Pharma (Issuer)
Meckler Jeffrey A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2019
6:17 AM | Intec Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2019
6:13 AM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/22/2019
7:00 AM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2019
3:42 PM | Intec Pharma (Issuer)
Silberman Issac (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2019
6:01 AM | Intec Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2019
6:00 AM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2019
4:27 PM | Intec Pharma (Issuer)
Meckler Jeffrey A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2019
4:21 PM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2019
11:16 PM | Intec Pharma (Filer)
| Form EFFECT
| |
03/28/2019
4:06 PM | Intec Pharma (Filer)
| Form 424B5
| |
03/11/2019
2:35 PM | Intec Pharma (Filer)
| Form CT ORDER
| |
03/01/2019
3:16 PM | Intec Pharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/28/2019
4:16 PM | Intec Pharma (Filer)
| Form DEF 14A
| |
02/27/2019
6:13 AM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2019
7:56 AM | Dexcel Pharma Technologies Ltd. (Filed by)
Intec Pharma (Subject)
| Form SC 13G/A
| |
02/14/2019
7:52 AM | Dexcel Pharma Technologies Ltd. (Reporting)
Intec Pharma (Issuer)
Oren Dan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/14/2019
7:28 AM | Intec Pharma (Subject)
venBio Select Advisor LLC (Filed by)
| Form SC 13G/A
| |
02/13/2019
12:33 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Intec Pharma (Subject)
| Form SC 13G/A
| |
02/12/2019
3:34 PM | Intec Pharma (Filer)
| Form PRE 14A
| |
02/07/2019
6:37 AM | Intec Pharma (Subject)
MEITAV DASH INVESTMENTS LTD (Filed by)
| Form SC 13G/A
| |
01/25/2019
3:33 PM | Intec Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2019
3:16 PM | GENDREAU R MICHAEL (Reporting)
Intec Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2019
3:14 PM | Intec Pharma (Issuer)
Linscott Walt Addison (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2019
3:12 PM | Intec Pharma (Issuer)
Navon Nadav (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2019
3:11 PM | Intec Pharma (Issuer)
Sassi Nir (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
